Impact of Device Free Summer Camp on Adolescent Mental Health and Wellbeing
IMPACT OF DEVICE FREE SUMMER CAMP ON ADOLESCENT MENTAL HEALTH AND WELLBEING
The goal of this clinical trial is to understand if attendance of a device-free summer camp, representing a shift from a digital environment to one that is device free and involves in person social interaction, can change mental health status and brain physiology in teens age 12-17. The main question it aims to answer is:
- How much is aggregate mental health and its various dimensions and components changed at the end of the camp attendance relative to the start of camp.
- How much is brain physiology, as measured by EEG change, changed at the end of camp relative to the start of camp.
Participants are recruited from among teens signed up to attend 2 or 3.5 week sessions a summer camp in Maine.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The goal of this clinical trial is to understand if attendance of a device-free summer camp, representing a shift from a digital environment to one that is device free and involves in person social interaction, can change mental health status and brain physiology in teens age 12-17. The main question it aims to answer is:
- How much is aggregate mental health and its various dimensions and components changed at the end of the camp attendance relative to the start of camp.
- How much is brain physiology, as measured by EEG change, changed at the end of camp relative to the start of camp.
Participants are recruited from among teens signed up to attend 2 or 3.5 week sessions a summer camp in Maine. Participants were asked to complete the MHQ, a comprehensive mental health assessment spanning 47 emotional, social and cognitive aspects and on the first day of camp and then again on the day before departure. In addition participants were asked questions on their school and camp experiences at the start and end of camp respectively.
Participants were also invited to participate in a socio-emotional task and/or have EEG measurements read on the first day of camp and the day before departure form camp. The socio-emotional task involved speaking or performing in front of a group of 4 or 5 people and rating one's own feelings performing this task as well as rating the perceived feelings of other group members when they were performing the task.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Maine
-
Porter, Maine, Stati Uniti, 04068
- Maine Teen Camp
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Attendance of Maine Teen Camp sessions during summer months of 2024 and 2025.
Exclusion Criteria:
- None
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Maine Teen Camp attendees
Attendance of a residential device-free summer camp for teens for 2 to 3.5 weeks characterized by in-person interaction and nature rich outdoor activities.
|
Attendance of a residential device-free summer camp in Maine for 2-3.5 weeks.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change from Baseline in Mental Health Quotient (MHQ) at End of Camp
Lasso di tempo: Baseline (Day 1) to end of camp attendance (up to 3.5 weeks).
|
The Mental Health Quotient or MHQ is an aggregate score of mental health computed from the 47 items of the MHQ assessment.
The score ranges from -100 to +200, where higher scores indicate better mental health outcomes.
Negative scores indicate significant symptoms that impact function (Distressed/Struggling range), while positive scores reflect the wide range of normal function (Enduring to Thriving).
Change is calculated by subtracting the baseline score from the end of camp score.
|
Baseline (Day 1) to end of camp attendance (up to 3.5 weeks).
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change from Baseline in Ratings of 47 MHQ Items After Camp Attendance
Lasso di tempo: Baseline (Day 1) to end of camp attendance (up to 3.5 weeks).
|
Difference in the ratings of each of the 47 items in the MHQ assessment spanning emotional, social, cognitive and physical capacities and problems.
Participants rate each item on a 9-point life impact scale.
|
Baseline (Day 1) to end of camp attendance (up to 3.5 weeks).
|
|
Change from Baseline in Resting-State Electroencephalography (EEG) measures
Lasso di tempo: Baseline (Day 1 of camp) and Post-Intervention (Final day of camp - 2.5-3 weeks later)
|
The outcome measure evaluates changes in EEG spectral metrics such as spectral slope, spectral bands and time domain metrics such as complexity/entropy measures such as Detrending Fluctuation Analysis (DFA), Lempel-Ziv Complexity and Sample Entropy measured during 3 minutes of EEG with eyes closed at the start and end of the camp session.
|
Baseline (Day 1 of camp) and Post-Intervention (Final day of camp - 2.5-3 weeks later)
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Tara Thiagarajan, PhD, Sapien Labs
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- MTC_24_25
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Periodo di condivisione IPD
Criteri di accesso alla condivisione IPD
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- ICF
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .